Abstract:Traumatic brain injury (TBI) is a worldwide core public health problem affecting mostly young male subjects. An alarming increase in incidence has turned TBI into a leading cause of morbidity and mortality in young adults as well as a tremendous resource burden on the health and welfare sector. Hormone dysfunction is highly prevalent during the acute phase of severe TBI. In particular, investigation of the luteinizing hormone (LH) and testosterone levels during the acute phase of severe TBI in male has identif… Show more
“…A pre-clinical rat study shows evidence that TBI leads to disruption of the estrous cycle with significantly reduced 17ߚ-estradiol (E2) hormone level 71 and spatial memory impairment compared to the sham group. Similarly, clinical studies indicate that TBI affects the circulating serum hormone levels in both females and males 72,73 . In females, testosterone increased with modest/no increase in estrogens 72 .…”
Section: Discussionmentioning
confidence: 97%
“…In females, testosterone increased with modest/no increase in estrogens 72 . In males, estrogen increases with a decrease in testosterone 73 . Therefore, specific studies to understand the role of sex hormones in neuroprotection and BBB breakdown after TBI are warranted.…”
Development of effective therapeutics for brain disorders is challenging, in particular, the blood-brain barrier (BBB) severely limits access of the therapeutics into the brain parenchyma. Traumatic brain injury (TBI) may lead to transient BBB permeability that affords a unique opportunity for therapeutic delivery via intravenous administration ranging from macromolecules to nanoparticles (NP) for developing precision therapeutics. In this regard, we address critical gaps in understanding the range/size of therapeutics, delivery window(s), and moreover the potential impact of biological factors for optimal delivery parameters. Here we show, for the first time, to the best of our knowledge, that 24 h post-focal TBI female mice exhibit a heightened macromolecular tracer and NP accumulation compared to male mice, indicating sexdependent differences in BBB permeability. Furthermore, we report for the first time the potential to deliver NP-based therapeutics within 3 d after focal injury in both female and male mice. The delineation of injury-induced BBB permeability with respect to sex and temporal profile is essential to more accurately tailor time-dependent precision and personalized nanotherapeutics.
“…A pre-clinical rat study shows evidence that TBI leads to disruption of the estrous cycle with significantly reduced 17ߚ-estradiol (E2) hormone level 71 and spatial memory impairment compared to the sham group. Similarly, clinical studies indicate that TBI affects the circulating serum hormone levels in both females and males 72,73 . In females, testosterone increased with modest/no increase in estrogens 72 .…”
Section: Discussionmentioning
confidence: 97%
“…In females, testosterone increased with modest/no increase in estrogens 72 . In males, estrogen increases with a decrease in testosterone 73 . Therefore, specific studies to understand the role of sex hormones in neuroprotection and BBB breakdown after TBI are warranted.…”
Development of effective therapeutics for brain disorders is challenging, in particular, the blood-brain barrier (BBB) severely limits access of the therapeutics into the brain parenchyma. Traumatic brain injury (TBI) may lead to transient BBB permeability that affords a unique opportunity for therapeutic delivery via intravenous administration ranging from macromolecules to nanoparticles (NP) for developing precision therapeutics. In this regard, we address critical gaps in understanding the range/size of therapeutics, delivery window(s), and moreover the potential impact of biological factors for optimal delivery parameters. Here we show, for the first time, to the best of our knowledge, that 24 h post-focal TBI female mice exhibit a heightened macromolecular tracer and NP accumulation compared to male mice, indicating sexdependent differences in BBB permeability. Furthermore, we report for the first time the potential to deliver NP-based therapeutics within 3 d after focal injury in both female and male mice. The delineation of injury-induced BBB permeability with respect to sex and temporal profile is essential to more accurately tailor time-dependent precision and personalized nanotherapeutics.
“…Similarly, clinical studies indicate that TBI affects the circulating serum hormone levels in both females and males. 57,60 In females, testosterone increased with modest/no increase in estrogens. 57 In males, estrogen increases with a decrease in testosterone.…”
Section: Discussionmentioning
confidence: 99%
“…57 In males, estrogen increases with a decrease in testosterone. 60 Therefore, comprehensive studies to understand the specific mechanism that drives the pathophysiological changes and the role of sex hormones in neuroprotection and BBB breakdown after TBI are warranted.…”
The development of effective therapeutics for brain disorders is challenging, in particular, the blood-brain barrier (BBB) severely limits access of the therapeutics into the brain parenchyma. Traumatic brain injury (TBI) may lead to transient BBB permeability that affords a unique opportunity for therapeutic delivery via intravenous administration ranging from macromolecules to nanoparticles (NPs) for developing precision therapeutics. In this regard, we address critical gaps in understanding the range/size of therapeutics, delivery window(s), and moreover, the potential impact of biological factors for optimal delivery parameters. Here we show, for the first time, to the best of our knowledge, that 24-h postfocal TBI female mice exhibit a heightened macromolecular tracer and NP accumulation compared with male mice, indicating sex-dependent differences in BBB permeability. Furthermore, we report for the first time the potential to deliver NP-based therapeutics within 3 days after focal injury in both female and male mice. The delineation of injury-induced BBB permeability with respect to sex and temporal profile is essential to more accurately tailor time-dependent precision and personalized nanotherapeutics.
“…Furthermore, there is proof that estrogen and progesterone have neuro-protective effects, suggesting that inadequate levels may have both acute and long-term consequences on the recovering brain (9). Decades of studies show that testosterone levels are low in 36.5–100% of patients with sTBI, however, the prognostic significance of testosterone levels remains controversial (10). Although insufficiency in hormones after TBI has become increasingly recognized, there are limited data focusing on TBI survivors regarding the role of sex hormones in predicting consciousness.…”
Objective:
The clinical course of unconsciousness after traumatic brain injury (TBI) is commonly unpredictable and it remains a challenge with limited therapeutic options. The aim of this study was to evaluate the early changes in serum sex hormone levels after severe TBI (sTBI) and the use of these hormones to predict recovery from unconsciousness with regard to sex.
Methods:
We performed a retrospective study including patients with sTBI. A statistical of analysis of serum sex hormone levels and recovery of consciousness at 6 months was made to identify the effective prognostic indicators.
Results:
Fifty-five male patients gained recovery of consciousness, and 37 did not. Of the female patients, 22 out of 32 patients regained consciousness. Male patients (
n
= 92) with sTBI, compared with healthy subjects (
n
= 60), had significantly lower levels of follicular stimulating hormone (FSH), testosterone and progesterone and higher levels of prolactin. Female patients (
n
= 32) with sTBI, compared with controls (
n
= 60), had significantly lower levels of estradiol, progesterone, and testosterone and significantly higher levels of FSH and prolactin. Testosterone significantly predicted consciousness recovery in male patients. Normal or elevated testosterone levels in the serum were associated with a reduced risk of the unconscious state in male patients with sTBI. For women patients with sTBI, sex hormone levels did not contribute to the prediction of consciousness recovery.
Conclusion:
These findings indicate that TBI differentially affects the levels of sex-steroid hormones in men and women patients. Plasma levels of testosterone could be a good candidate blood marker to predict recovery from unconsciousness after sTBI for male patients.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.